Showing results (41-50 of 135) with videos related to
Sort By:
Pageof 14
The Journal of Biological Chemistry|December 15, 2010
Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate A{beta} formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD miceSadim Jawhar, Oliver Wirths, Stephan Schilling, et al.Journal of Alzheimer'S Disease Reports|December 24, 2019
Reduced Acoustic Startle Response and Prepulse Inhibition in the Tg4-42 Model of Alzheimer's DiseaseMarius E Sichler, Maximilian J Löw, Eva M Schleicher, et al.Journal of Alzheimer'S Disease : JAD|January 11, 2012
Antibody 9D5 recognizes oligomeric pyroglutamate amyloid-β in a fraction of amyloid-β deposits in Alzheimer's disease without cross-reactivity with other protein aggregatesVivek Venkataramani, Oliver Wirths, Herbert Budka, et al.The Psychiatric Clinics of North America|November 17, 2022
Comorbidity and Management of Concurrent Psychiatric and Medical DisordersThomas A Bayer, Ryan Van Patten, Dylan Hershkowitz, et al.The Journal of Biological Chemistry|July 13, 2004
Human BACE forms dimers and colocalizes with APPAriane Schmechel, Markus Strauss, Andrea Schlicksupp, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|May 6, 2009
Circulating immune complexes of Abeta and IgM in plasma of patients with Alzheimer's diseaseAndrea Marcello, Oliver Wirths, Thomas Schneider-Axmann, et al.Frontiers in Neuroscience|October 5, 2020
miRNA Alterations Elicit Pathways Involved in Memory Decline and Synaptic Function in the Hippocampus of Aged Tg4-42 MiceYvonne Bouter, Tim Kacprowski, Fanny Rößler, et al.Journal of Chemical Neuroanatomy|March 30, 2010
Concomitant detection of beta-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic miceWolfgang Härtig, Simone Goldhammer, Ute Bauer, et al.Current Topics in Behavioral Neurosciences|May 15, 2013
Prolonged running, not fluoxetine treatment, increases neurogenesis, but does not alter neuropathology, in the 3xTg mouse model of Alzheimer's diseaseMichael W Marlatt, Michelle C Potter, Thomas A Bayer, et al.The Journal of Biological Chemistry|October 7, 2004
Clioquinol mediates copper uptake and counteracts copper efflux activities of the amyloid precursor protein of Alzheimer's diseaseCarina Treiber, Andreas Simons, Markus Strauss, et al.Pageof 14